BCMA-targeted immunotherapy for multiple myeloma
Abstract B cell maturation antigen (BCMA) is a novel treatment target for multiple myeloma (MM) due to its highly selective expression in malignant plasma cells (PCs). Multiple BCMA-targeted therapeutics, including antibody-drug conjugates (ADC), chimeric antigen receptor (CAR)-T cells, and bispecif...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2020-09-01
|
| Serier: | Journal of Hematology & Oncology |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s13045-020-00962-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
